Concepedia

Lynn Miesel

LM

27

Publications

1.1K

Citations

20

H-Index

1994

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

WuXi AppTec (China)

University of Utah

Cidara Therapeutics (United States)

Lynn Miesel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and drug discovery.

Top concepts

Publications per year

1994–2024

27

Publications

27

NADH Dehydrogenase Defects Confer Isoniazid Resistance and Conditional Lethality in <i>Mycobacterium smegmatis</i>

Lynn Miesel, Torin R. Weisbrod, Jovita Marcinkeviciene et al. · Journal of Bacteriology · 1998 · 153 citations · Full text

Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus

Joann Huber, Robert G. K. Donald, Sang Ho Lee et al. · Chemistry & Biology · 2009 · 112 citations

, , +12

Broadening the Spectrum of β-Lactam Antibiotics through Inhibition of Signal Peptidase Type I

Alex G. Therien, Joann Huber, Kenneth E. Wilson et al. · Antimicrobial Agents and Chemotherapy · 2012 · 77 citations · Full text

, , +21

Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents

Sheo B. Singh, David E. Kaelin, Jin Wu et al. · ACS Medicinal Chemistry Letters · 2014 · 75 citations · Full text

, , +16

Potent LpxC Inhibitors with <i>In Vitro</i> Activity against Multidrug-Resistant Pseudomonas aeruginosa

Kevin M. Krause, Cat M. Haglund, Christy M. Hebner et al. · Antimicrobial Agents and Chemotherapy · 2019 · 59 citations · Full text

Rows per page

1–5 of 27